Nur Nicholson

Insider Reports History

Entity
Individual
Location
Apellis Pharmaceuticals, Inc., 100 5 Th Avenue, 3 Rd Floor, Waltham, MA
Signature
/s/ David Watson, attorney-in-fact for Nur Nicholson
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Nur Nicholson:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Apellis Pharmaceuticals, Inc. Chief Technical Officer Common Stock 56.3K $3.27M $58.13 Mar 13, 2024 Direct
Apellis Pharmaceuticals, Inc. Chief Technical Officer Stock Option (Right to Buy) 28.4K $1.88M $66.30 Jan 16, 2024 Direct

Insider Reports Filed by Nur Nicholson

Symbol Company Period Transactions Value $ Form Type Date Filed Role
APLS Apellis Pharmaceuticals, Inc. Mar 13, 2024 2 -$646K 4 Mar 14, 2024 Chief Technical Officer
APLS Apellis Pharmaceuticals, Inc. Jan 29, 2024 1 -$53.6K 4 Jan 31, 2024 Chief Technical Officer
APLS Apellis Pharmaceuticals, Inc. Jan 22, 2024 1 -$169K 4 Jan 23, 2024 Chief Technical Officer
APLS Apellis Pharmaceuticals, Inc. Jan 16, 2024 3 $1.76M 4 Jan 17, 2024 Chief Technical Officer
APLS Apellis Pharmaceuticals, Inc. Sep 18, 2023 4 -$612K 4 Sep 19, 2023 Chief Technical Officer
APLS Apellis Pharmaceuticals, Inc. Feb 21, 2023 3 -$48.3K 4 Feb 22, 2023 Chief Technical Officer
APLS Apellis Pharmaceuticals, Inc. Jan 27, 2023 1 -$29.1K 4 Jan 30, 2023 Chief Technical Officer
APLS Apellis Pharmaceuticals, Inc. Jan 20, 2023 1 -$106K 4 Jan 24, 2023 Chief Technical Officer
APLS Apellis Pharmaceuticals, Inc. Apr 25, 2022 4 $1.87M 4 Jan 17, 2023 Chief Technical Officer
APLS Apellis Pharmaceuticals, Inc. Jan 28, 2022 1 -$25.1K 4 Feb 1, 2022 Chief Technical Officer
APLS Apellis Pharmaceuticals, Inc. Jan 21, 2022 2 $0 4 Jan 25, 2022 Chief Technical Officer